‌

US Patent 10494647 HIV pre-immunization and immunotherapy

Patent 10494647 was granted and assigned to American Gene Technologies on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

American Gene Technologies

Current Assignee

American Gene Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

December 3, 2019

Patent Application Number

16218010

Date Filed

December 12, 2018

Patent Citations

US Patent 10137144 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10023880 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10036038 HIV pre-immunization and immunotherapy

US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10233464 HIV pre-immunization and immunotherapy

Patent Citations Received

US Patent 12090200 Methods of producing cells resistant to HIV infection

0

US Patent 11911458 HIV pre-immunization and immunotherapy

0

Patent Primary Examiner

Barry A Chestnut

Patent abstract

The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10494647 HIV pre-immunization and immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.